Virtual Rehabilitation for Cancer Survivors
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a virtual rehabilitation program called CaRE@Home for individuals who have completed primary treatment for certain cancers, such as breast or colorectal cancer. The goal is to determine if this 8-week program can enhance daily activities, physical and social well-being, and reduce anxiety. Participants will be randomly assigned to either the virtual program or a usual care group for comparison. Those who completed their main cancer treatment within the last two years and face cancer-related challenges affecting daily life might be suitable candidates. As an unphased trial, this study offers a unique opportunity to contribute to innovative cancer recovery research and potentially improve personal well-being.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, it mentions that participants can be on certain ongoing therapies like trastuzumab, immunotherapy, and others, so it seems likely you can continue your current medications.
What prior data suggests that this virtual cancer rehabilitation program is safe for cancer survivors?
Research has shown that the CaRE@Home program is a safe and well-received option for cancer survivors. In a previous study, participants found the program easy to use and had a positive experience, with no major reports of negative side effects or issues.
The CaRE@Home program focuses on virtual rehabilitation, which has been proven to improve physical fitness and activity levels in cancer patients. By using online tools, it aims to help people recover and enhance their quality of life after cancer treatment. This approach has been successfully adapted to online formats, making it easy and convenient for users. Overall, the evidence suggests that the program is safe and could be beneficial.12345Why are researchers excited about this trial?
Researchers are excited about the CaRE@Home intervention because it offers a new way for cancer survivors to engage in rehabilitation from the comfort of their homes. Unlike traditional in-person physical therapy sessions, which can be time-consuming and logistically challenging, CaRE@Home uses virtual technology to deliver personalized rehabilitation programs. This approach not only makes it more convenient for patients but also potentially increases adherence to rehabilitation protocols, as it can be tailored to fit individual schedules and needs. By leveraging digital tools, CaRE@Home aims to enhance the quality of life for cancer survivors, making rehabilitation more accessible and efficient.
What evidence suggests that the CaRE@Home intervention might be an effective treatment for cancer-related impairments?
Research has shown that the CaRE@Home program, available to participants in this trial, is a promising online rehabilitation tool for cancer survivors. A small initial study found it practical and well-received, suggesting it may aid in recovery. Online rehabilitation programs like CaRE@Home have improved the quality of life for cancer patients, offering clear benefits. Participants might experience enhancements in physical and social activities and reduced anxiety. Although more research is needed, early results support its potential effectiveness for addressing cancer-related challenges.12367
Who Is on the Research Team?
Jennifer Jones, PhD
Principal Investigator
UHN Princess Margaret Cancer Centre
Are You a Good Fit for This Trial?
This trial is for cancer survivors aged 18+ who've finished primary treatment within the last 2 years. It's open to those with breast, colorectal, head and neck cancers or lymphoma if they're responding well to ongoing therapies like immunotherapy. Participants need good enough English for the intervention, internet access, and a WHO-DAS score over 5 indicating a need for rehab.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo an 8-week virtual cancer rehabilitation program (CaRE@Home) with weekly e-modules, exercise prescriptions, and counseling
Follow-up
Participants are monitored for safety and effectiveness after treatment with assessments at 3 and 6 months post-intervention
Maintenance Assessment
Additional follow-up at 6 months post-intervention to assess maintenance of treatment gains
What Are the Treatments Tested in This Trial?
Interventions
- CaRE@Home intervention
CaRE@Home intervention is already approved in Canada for the following indications:
- Rehabilitation for cancer survivors with identified cancer-related impairments
Find a Clinic Near You
Who Is Running the Clinical Trial?
University Health Network, Toronto
Lead Sponsor